** Shares of medical device maker Dexcom DXCM.O rise 3.9% to $72.98 premarket
** Late on Thursday, co posted Q1 sales of $1.04 bln, above analysts' est of $1.02 bln - LSEG
** Co reiterated its annual sales forecast of $4.60 bln; analysts were expecting 2025 sales of $4.61 bln - LSEG
** J.P.Morgan analyst Robbie Marcus said the co has taken a "conservative approach" and expects to see "outperformance over the balance of the year"
** Co reports Q1 adj profit of 32 cents/share, compared with est of 33 cents/share - LSEG
** As of last close, stock down 9.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。